Yılmaz Mehmet Birhan
Department of Cardiology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey.
Turk Kardiyol Dern Ars. 2017 Sep;45(Suppl 4):8-9. doi: 10.5543/tkda.2017.52358.
The GEMINI-ACS-1 trial has recently been published. It was designed to test whether low dose rivaroxaban as an antithrombotic agent is as safe as aspirin in patients with acute coronary syndromes (ACS). The trial is important to set light to future of ACS management.
